Stockscreener 앱 받기
2.96
0.67%
-0.02
시간 외 거래:
2.92
-0.04
-1.35%
전일 마감가:
$2.98
열려 있는:
$2.97
하루 거래량:
3.61M
Relative Volume:
0.66
시가총액:
$703.91M
수익:
-
순이익/손실:
$-252.18M
주가수익비율:
-2.7925
EPS:
-1.06
순현금흐름:
$-185.29M
1주 성능:
-3.27%
1개월 성능:
-30.52%
6개월 성능:
+16.08%
1년 성능:
-45.29%
1일 변동 폭
$2.85
$3.00
1주일 범위
$2.77
$3.085
52주 변동 폭
$1.26
$7.30
사나 바이오테크놀로지 Stock (SANA) Company Profile
명칭
Sana Biotechnology Inc
전화
(206) 701-7914
주소
188 EAST BLAINE STREET, SUITE 400, SEATTLE
SANA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SANA
Sana Biotechnology Inc
|
2.96 | 756.60M | 0 | -252.18M | -185.29M | -1.06 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
사나 바이오테크놀로지 Stock (SANA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-03 | 재개 | Morgan Stanley | Overweight |
| 2025-03-18 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | 개시 | Jefferies | Buy |
| 2025-01-08 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-11-05 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | 개시 | Rodman & Renshaw | Buy |
| 2024-01-16 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-05 | 개시 | Citigroup | Buy |
| 2023-08-14 | 개시 | TD Cowen | Market Perform |
| 2023-05-02 | 개시 | H.C. Wainwright | Neutral |
| 2021-03-01 | 개시 | BofA Securities | Buy |
| 2021-03-01 | 개시 | Goldman | Neutral |
| 2021-03-01 | 개시 | JP Morgan | Neutral |
| 2021-03-01 | 개시 | Morgan Stanley | Overweight |
모두보기
사나 바이오테크놀로지 주식(SANA)의 최신 뉴스
Technical signs of recovery in Sana Biotechnology Inc.Earnings Recap Summary & Weekly High Return Stock Opportunities - Newser
Sana Reports Promising Diabetes Cell Therapy Data at ADA Meeting - MSN
Certain Common Stock of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 6-SEP-2025. - MarketScreener
Certain Stock Options of Sana Biotechnology, Inc. are subject to a Lock-Up Agreement Ending on 6-SEP-2025. - MarketScreener
Is Sana Biotechnology Inc.’s ROE strong enoughQuarterly Earnings Summary & Reliable Entry Point Trade Alerts - خودرو بانک
Is Sana Biotechnology Inc. exposed to political riskTrade Signal Summary & Weekly Momentum Picks - خودرو بانک
Does Sana Biotechnology Inc. fit your quant trading model2025 Fundamental Recap & Fast Gain Swing Trade Alerts - Newser
Sana Biotechnology shares rise 1.01% premarket after analyst presentations at Wells Fargo and Morgan Stanley conferences. - AInvest
How to build a custom watchlist for Sana Biotechnology Inc.July 2025 Spike Watch & Real-Time Volume Spike Alerts - Newser
What MACD and RSI say about Sana Biotechnology Inc.Quarterly Trade Summary & Verified Entry Point Signals - Newser
Combining machine learning predictions for Sana Biotechnology IncDividend Hike & Real-Time Stock Entry Alerts - Newser
Sana Biotechnology Announces Leadership Transition - TipRanks
Sana Biotechnology announces retirement of executive vice president and appointment of new chief legal officer - Investing.com
Sana Biotechnology Inc. stock chart pattern explainedWall Street Watch & Verified Momentum Stock Ideas - Newser
What’s Sana Biotechnology Inc.’s historical returnMarket Activity Summary & Safe Capital Growth Tips - خودرو بانک
What recovery options are there for Sana Biotechnology Inc.Weekly Trend Summary & Weekly High Return Stock Opportunities - Newser
Sana Biotechnology’s Position in the Engineered Cell Therapy Landscape - AInvest
Is Sana Biotechnology Inc. showing signs of accumulationGold Moves & Low Drawdown Momentum Trade Ideas - Newser
Market Outlook: Is Sana Biotechnology Inc.’s ROE strong enough2025 Market WrapUp & Safe Entry Trade Reports - خودرو بانک
Can a trend reversal in Sana Biotechnology Inc. lead to recoveryDip Buying & Free Fast Entry Momentum Trade Alerts - Newser
Combining machine learning predictions for Sana Biotechnology Inc.2025 Winners & Losers & Weekly Consistent Profit Watchlists - Newser
Using Python tools to backtest Sana Biotechnology Inc. strategiesWall Street Watch & Community Verified Swing Trade Signals - Newser
Is Sana Biotechnology Inc. reversing from oversold territoryWeekly Trade Recap & Precise Buy Zone Identification - Newser
What to expect from Sana Biotechnology Inc. in the next 30 days2025 Volatility Report & Weekly High Momentum Picks - Newser
Applying sector rotation models to Sana Biotechnology Inc.2025 Support & Resistance & Weekly Chart Analysis and Trade Guides - Newser
Multi factor analysis applied to Sana Biotechnology Inc.Market Activity Recap & Weekly Momentum Picks - Newser
Can volume confirm reversal in Sana Biotechnology Inc.July 2025 Catalysts & High Accuracy Swing Trade Signals - Newser
Building trade automation scripts for Sana Biotechnology Inc.Portfolio Growth Summary & Daily Technical Stock Forecast Reports - Newser
Real time social sentiment graph for Sana Biotechnology Inc.Weekly Stock Summary & Daily Technical Stock Forecast Reports - Newser
Sana Biotechnology shares rise 2.11% intraday after presenting at Citi's Biopharma Back. - AInvest
What the charts say about Sana Biotechnology Inc. todaySell Signal & AI Enhanced Trade Execution Alerts - Newser
Is it time to cut losses on Sana Biotechnology Inc.Analyst Downgrade & Weekly Top Gainers Alerts - Newser
Technical signs of recovery in Sana Biotechnology IncJuly 2025 PostEarnings & Verified Trade Idea Suggestions - Newser
Detecting support and resistance levels for Sana Biotechnology Inc.2025 Volume Leaders & Intraday High Probability Setup Alerts - Newser
Sana Biotechnology Inc. stock trend forecastWeekly Earnings Recap & Expert Approved Trade Ideas - Newser
Reversal indicators forming on Sana Biotechnology Inc. stockQuarterly Trade Summary & Weekly Chart Analysis and Trade Guides - Newser
What high frequency data says about Sana Biotechnology Inc.Earnings Trend Report & Reliable Entry Point Trade Alerts - Newser
Sana Biotechnology’s Strategic Momentum in Engineered Cell Therapies: Evaluating Near-Term Catalysts and Investor Visibility Ahead of Key September Conference Appearances - AInvest
Will Sana Biotechnology Inc. benefit from geopolitical trends2025 Technical Patterns & AI Forecasted Entry and Exit Points - خودرو بانک
Will Sana Biotechnology Inc. bounce back from current supportPortfolio Value Report & Verified Short-Term Trading Plans - Newser
What is the long term forecast for Sana Biotechnology Inc. stockJuly 2025 EndofMonth & Verified Entry Point Signals - خودرو بانک
Is Sana Biotechnology Inc. a strong candidate for buy and holdMarket Trend Summary & Daily Price Action Insights - خودرو بانک
사나 바이오테크놀로지 (SANA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
사나 바이오테크놀로지 주식 (SANA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Cassidy Bernard J | EVP & General Counsel |
Mar 07 '25 |
Option Exercise |
0.00 |
11,041 |
0 |
115,823 |
| Harr Steve | President & CEO |
Mar 07 '25 |
Option Exercise |
0.00 |
50,000 |
0 |
7,889,750 |
| Wyrick Susan D. | See Remarks |
Mar 02 '25 |
Option Exercise |
0.00 |
1,525 |
0 |
155,471 |
1.40%
자본화:
|
볼륨(24시간):